
SMALL MOLECULE OUTSOURCING

Local Delivery For Treatment Of Lung Cancer
Explore two case studies where lung cancer therapies were delivered to the lung by dry powder inhaler in a rat model and evaluated for efficacy, confirming local delivery is a promising route to treat lung cancer.

Cambrex Scientist Spotlight: Kelly McGuill
McGuill is dedicated to inspiring the next generation of scientists. Her commitment to quality ensures that clients stay compliant and focused on advancing to the next phase of their projects.

Cambrex Scientist Spotlight: Elena Bejan
Holding a Ph.D. in organic chemistry from Paris-Sud University and an MBA from the Rotman School of Management, Bejan leads R&D efforts at Cambrex with a focus on scientific innovation.

Integrating Early Development With Clinical Supply
In the era of seamless development, reducing time to the clinic and getting rapid approval is key. An integrated approach can accelerate timelines, avoid communication pitfalls, and improve outcomes.

Patient- And Planet-Centric Bioavailability And Sustained Delivery
By reducing the size of drug particles, nanoforming offers new opportunities — from increased bioavailability to sustained drug delivery. Discover the potential benefits supported by case studies.

Chromatography, Purification & Isolation Technologies
Explore options for the field of chromatography and allied downstream technologies and how these technologies are applied to design favorable processes in order to generate true customer benefit.

Improve The Bioavailability Of Poorly Soluble Drugs
KinetiSol is a fusion-based, solvent-free process that utilizes frictional and shear energies — in a fraction of the time of other amorphous solid dispersion technologies.

From Bench To Batch: Strategies For Scaling HPAPI Production
Highly potent materials bring additional challenges to manufacturing processes. Examine considerations for optimizing HPAPI production methods to reduce risk and deliver therapies to patients with speed.

How To Design An HPAPI Plant And Its Containment Systems
Dr. Friederike Hermann, head of occupational hygiene and biosafety, shares her expertise on requirements and evaluating the right containment that meets the needs of all process steps and stakeholders.

Understanding FDA Calibration Requirements And Best Practices For Reducing Risks
Become equipped with the tools and strategies needed to strengthen your calibration efforts and better position your organization for success in regulatory audits.

Continuous Flow Techniques For Fine Chemical Manufacturing
Explore the advantages and challenges of continuous flow processes and the concept of mini-monoplant technology, along with examples that demonstrate the versatility of continuous processing.

Fostering A Collaborative, Cross-Functional Approach
Our collaborative environment ensures efficient project execution and thorough product testing across multiple sites, consistently delivering client satisfaction.

Cambrex Scientist Spotlight: Luigi Bellone
Luigi Bellone, Head of Quality Assurance in Paullo, Milan, brings over 20 years of experience in quality assurance (QA), quality control (QC), and regulatory compliance within the pharmaceutical industry.

The Future Of Oral Solid Dose Development And Innovation
Tom Sellig, CEO of Adare, discusses the ongoing relevance of small molecules, oral solid dose development, trends like GLP-1, and innovations like 3D printing in pharmaceuticals.

How To Deal With The Complexity Of Drugs In Clinical Development
Discover how to advance new compounds with complex chemistry through each stage of development by refining processes to give fit-for-purpose manufacturability and yields.

Nanoscale Technology's Potential: A Fireside Chat With Industry Leaders
Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.

Understanding Nitrosamines: Key Regulations And Best Practices
Gain expert insights into nitrosamine regulations and discover practical strategies for ensuring compliance and safeguarding product safety.

Rapid Developability Assessment Of Early Phase Molecules
A case study illustrating how to use PBPK modeling, the developability classification system, and the biopharmaceutics drug distribution classification system to facilitate development of a molecule.

How Drug Delivery Is Enabling A Clinical Trial For Glioblastoma
Discover highly promising in-vivo data, enabled by a nanoformed drug product for the treatment of glioblastoma multiforme (GBM).

Innovative Technology For Developing, Scaling Peptide-Based Therapeutics
Watch as experts walk through several technologies and case studies, focusing on liquid-phase peptide synthesis, crystallization, method development for impurity analysis, and more.

Considerations For Complex Formulations: How To Simplify Your Outsourcing
Experts share the necessary development and manufacturing considerations for a smooth tech transfer, exploring these challenges in depth, and discuss the questions you should be asking your manufacturer.

3D Screen Printing: Breakthrough Solutions For Patient-Centric Therapies
Explore 3D screen printing’s potential to revolutionize pharmaceutical manufacturing with scalable, customizable, multi-drug tablets and precise, patient-centric drug release profiles.

Environmental Sustainability: Wastewater Incineration Reduction
Discover an approach to wastewater treatment that reduces the environmental impact of small molecules production and introduces advanced treatment methodologies to avoid wastewater incineration.

Challenges Of Moving A Bioconjugate Candidate From Clinic To Market
Drug developers must successfully navigate the path to market, under the growing pressure of regulation and competition, and while carefully managing technical and financial risk.

Challenges With Pediatric Flavors For Taste Enhancement And Modulation
Taste masking for children can present unique challenges for drug developers. Learn how we can use flavor, not just to provide a desired taste, but also to provide taste masking.

Improve The Performance Of Your Small And Large Molecule Medicines
Explore the latest in nanotechnology advancements including recent clinical data, formulation applications, and API optimization to NanoImprove formulations.

CESS Technology
Learn how the award-winning CESS® technology can be used in Nanoforming™ future medicines to increase bioavailability for molecules with poor solubility.

Expanding The OSD Toolbox
This session is designed to provide practical solutions for enhancing bioavailability and scalability in pharmaceutical formulations.

The Fusion-Based, Solvent-Free Process Disrupting Spray Drying
Review a commercially-ready process capable of reproducing spray-dried dispersions with less manufacturing complexity and environmental impact, and out-designing and outperforming spray drying.

Collaboration With Clients
If you're looking for a dedicated partner who prioritizes trust, transparent communication, and delivering results that exceed expectations, let's work together to drive your project's success and create lasting impact.

Cambrex Scientist Spotlight: Myoung Goo Kim
Myoung Goo Kim, Chemistry R&D Manager in High Point, NC, is a recognized expert in process chemistry, specializing in API manufacturing for Cambrex’s clients.

How To Safely Handle Your Antibody Drug Conjugate
Internal specialized occupational toxicology and industrial hygiene knowledge can help solve the mystery of safe handling ADCs.

Solvent-Free, Fusion-Based Amorphic Dispersion Process
Discover a solvent-free, fusion-based process that leverages frictional and shear forces to rapidly convert crystalline drugs and polymers into amorphous solid dispersions (ASDs).

This Is Your Team At Cambrex
We’re committed to helping our customers succeed and tackling challenges of any size. Meet the team of experts you’ll love collaborating with.

Scaling Up A Revolutionary Amorphous Solid Dispersion Platform
Process parameter and quality attribute relationships, including those for typical pre- and post-ASD unit operations, will be explored in the context of real-world examples.

Nanoparticle Enabled Formulation And Drug Delivery Solutions
Discover how revolutionary and environmentally sustainable nanoparticle technologies coupled with innovative formulation approaches can address drug solubility issues and add value for patients.